Guest appearance

Oncology eCOA - How the New FDA Draft Guidelines Change COA Implementation, Upcoming Webinar Hosted by Xtalks

Thursday, October 14, 2021 - 1:30pm

In this webinar, Signant 's clinical experts provide a summary, as well as interpretation and analysis, of the draft guidance with a view to establish foundations for future study design and planning.

Key Points: 
  • In this webinar, Signant 's clinical experts provide a summary, as well as interpretation and analysis, of the draft guidance with a view to establish foundations for future study design and planning.
  • For more information, or to register for this event, visit Oncology eCOA What the New FDA Draft Guidelines Tell Us.
  • Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community.
  • Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.)

Industry-veteran Elisa Cascade Joins Science 37 as Chief Product Officer; Chris Ceppi appointed Chief Technology Officer

Wednesday, October 13, 2021 - 12:55pm

LOS ANGELES, Oct. 13, 2021 (GLOBE NEWSWIRE) -- Science 37, the Operating System for todays more agile clinical trials, announced Elisa Cascade has joined Science 37 and its senior executive team as Chief Product Officer.

Key Points: 
  • LOS ANGELES, Oct. 13, 2021 (GLOBE NEWSWIRE) -- Science 37, the Operating System for todays more agile clinical trials, announced Elisa Cascade has joined Science 37 and its senior executive team as Chief Product Officer.
  • Science 37 veteran Chris Ceppi has been appointed to serve as Chief Technology Officer.
  • Science 37 veteran and architect of the Science 37 technology platform, Mr. Ceppi serves in a new leadership role as Chief Technology Officer to provide greater focus on platform and data infrastructure as a service and competitive advantage.
  • As the pioneer of the decentralized clinical trial model, Science 37 has been leading the way to a more patient-centric future for research and driving toward a more adaptable, agile clinical trial, said Elisa Cascade, Chief Product Officer of Science 37.

Global ePRO, E-Patient Diaries and eCOA Industry (2020 to 2027) - Market Trajectory & Analytics - ResearchAndMarkets.com

Friday, October 8, 2021 - 6:02pm

The "ePRO, E-Patient Diaries and eCOA - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "ePRO, E-Patient Diaries and eCOA - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
  • After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the E-Patient Diaries segment is readjusted to a revised 15.7% CAGR for the next 7-year period.
  • The U.S. Market is Estimated at $366.9 Million, While China is Forecast to Grow at 14.2% CAGR
    The ePRO, E-Patient Diaries and eCOA market in the U.S. is estimated at US$366.9 Million in the year 2020.
  • Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 13.1% and 12.6% respectively over the 2020-2027 period.

Signant Health Announces Enhancements to SmartSignals™ RTSM Platform

Wednesday, October 6, 2021 - 2:00pm

PHILADELPHIA, Oct. 6, 2021 /PRNewswire/ -- Signant Health , the leader in evidence generation for modern clinical trials, announced today the launch of key enhancements to its SmartSignals Randomization and Trial Supply Management (RTSM) solution.

Key Points: 
  • PHILADELPHIA, Oct. 6, 2021 /PRNewswire/ -- Signant Health , the leader in evidence generation for modern clinical trials, announced today the launch of key enhancements to its SmartSignals Randomization and Trial Supply Management (RTSM) solution.
  • SmartSignals RTSM already has an agile delivery model that accelerates system deployment in just one to four weeks and accommodates rapid protocol amendments.
  • Dynamic inventory algorithms combined with the ability to integrate with clinical supply management systems enables SmartSignals RTSM to maximize supply efficiencies across a compound or program.
  • "Our user-focused RTSM enhancements will prepare sponsors, CROs, and sites for the complexities inherent in the new era of clinical research."

Signant Health Announces Enhancements to SmartSignals™ RTSM Platform

Wednesday, October 6, 2021 - 2:00pm

PHILADELPHIA, Oct. 6, 2021 /PRNewswire/ -- Signant Health, the leader in evidence generation for modern clinical trials, announced today the launch of key enhancements to its SmartSignals Randomization and Trial Supply Management (RTSM) solution. Enhanced functionalities include new dashboards, contemporary interface designs, enhanced reporting, and improvements to self-service user management. This release will further enable the evolving clinical research landscape in which trials are growing in size and complexity, as well as becoming increasingly decentralized.

Key Points: 
  • PHILADELPHIA, Oct. 6, 2021 /PRNewswire/ -- Signant Health , the leader in evidence generation for modern clinical trials, announced today the launch of key enhancements to its SmartSignals Randomization and Trial Supply Management (RTSM) solution.
  • SmartSignals RTSM already has an agile delivery model that accelerates system deployment in just one to four weeks and accommodates rapid protocol amendments.
  • Dynamic inventory algorithms combined with the ability to integrate with clinical supply management systems enables SmartSignals RTSM to maximize supply efficiencies across a compound or program.
  • "Our user-focused RTSM enhancements will prepare sponsors, CROs, and sites for the complexities inherent in the new era of clinical research."

Valued to be $2.8 Billion by 2026, ePRO, E-Patient Diaries and eCOA Slated for Robust Growth Worldwide

Tuesday, October 5, 2021 - 4:30pm

We are offering a complimentary access to qualified executives driving strategy, business development, sales & marketing, and product management roles at featured companies.

Key Points: 
  • We are offering a complimentary access to qualified executives driving strategy, business development, sales & marketing, and product management roles at featured companies.
  • Previews provide deep insider access to business trends; competitive brands; domain expert profiles; and market data templates and much more.
  • Preview Registry
    ePRO, eCOA, and e-patient diaries are among the technologies that are enabling healthcare providers and clinical trial companies to enable electronic data capture and analysis.
  • This segment currently accounts for a 21.6% share of the global ePRO, E-Patient Diaries and eCOA market.

Clinical Trial Innovation Pioneer Craig Lipset Joins Spencer Health Solutions Advisory Board

Tuesday, October 5, 2021 - 1:10pm

Craig Lipset, a pioneer in clinical trial innovation for Pfizer, has joined the Spencer Health Solutions advisory board.

Key Points: 
  • Craig Lipset, a pioneer in clinical trial innovation for Pfizer, has joined the Spencer Health Solutions advisory board.
  • Lipset is an active advisor for pharmaceutical companies, technology leaders, and investors seeking to identify and scale innovative solutions for clinical trials.
  • He previously led clinical trial innovation for Pfizer and was an advisor for venture capital investments.
  • "Now is the time to deliver the future of clinical trials, accelerate drug development and improve the lives of patients," Lipset said.

Global eClinical Solutions Market (2021 to 2026) - Need for Improved Data Standardization is Driving Growth - ResearchAndMarkets.com

Thursday, September 30, 2021 - 5:18pm

Based on delivery mode, the global eClinical solutions market is segmented into web-hosted (on-demand), licensed enterprise (on-premises), and cloud-based (SaaS) solutions.

Key Points: 
  • Based on delivery mode, the global eClinical solutions market is segmented into web-hosted (on-demand), licensed enterprise (on-premises), and cloud-based (SaaS) solutions.
  • In 2020, the web-hosted (on-demand) segment commanded the largest share of the global eClinical solutions market.
  • Based on the clinical trial phase, the eClinical solutions market has been segmented into phase I, phase II, phase III, and phase IV trials.
  • The phase III clinical trials segment accounted for the largest share of the eClinical solutions market in 2020.

Medrio, Inc. and PHARMASEAL Unite to Offer Streamlined End-to-End Data Collection and Management for Clinical Studies

Tuesday, September 28, 2021 - 2:00pm

"Our new partnership with PHARMASEAL gives our customers expanded visibility and insights into their clinical trial data through a unified system.

Key Points: 
  • "Our new partnership with PHARMASEAL gives our customers expanded visibility and insights into their clinical trial data through a unified system.
  • PHARMASEAL was founded in 2016 with a vision to create smarter technology and innovative products for the improvement of health.
  • "We are thrilled to partner with PHARMASEAL to offer our customers a world-class CTMS and eTMF solution that seamlessly integrates with Medrio's flexible data collection and management tools.
  • Take control of your clinical research and studies with Medrio's full-service suite of eClinical Data Management solutions.

Virtual Clinical Trials - Unifying Trials from Patient Engagement Through Study Closeout, Upcoming Webinar Hosted by Xtalks

Tuesday, August 31, 2021 - 1:30pm

It is more important than ever to have your patient engagement activities unified with your data management.

Key Points: 
  • It is more important than ever to have your patient engagement activities unified with your data management.
  • In this webinar, EvidentIQ will show you how you can have a fully unified clinical trial, including eConsent, eCOA, EDC, IWRS, CTMS, eTMF and so much more.
  • The goal is to bring the industry into a single unified platform across the entire trial lifecycle, including patient insights, clinical data management and clinical study and document management.
  • For more information, or to register for this event, visit Virtual Clinical Trials Unifying Trials from Patient Engagement Through Study Closeout.